about
Neuronal injury-induced expression and release of apolipoprotein E in mixed neuron/glia co-cultures: nuclear factor kappaB inhibitors reduce basal and lesion-induced secretion of apolipoprotein EMicroglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharideMolecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistryIncreased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautographyMicroglial cells in astroglial cultures: a cautionary note.Alterations in CD200-CD200R1 System during EAE Already Manifest at Presymptomatic Stages.Pro-inflammatory gene expression and neurotoxic effects of activated microglia are attenuated by absence of CCAAT/enhancer binding protein β.Modelling neuroinflammation in vitro: a tool to test the potential neuroprotective effect of anti-inflammatory agentsPassive experimental autoimmune encephalomyelitis in C57BL/6 with MOG: evidence of involvement of B cells.Etoposide-induced PC12 cell death: apoptotic morphology without oligonucleosomal DNA fragmentation or dependency upon de novo protein synthesis.Myeloid C/EBPβ deficiency reshapes microglial gene expression and is protective in experimental autoimmune encephalomyelitis.CCAAT/enhancer binding protein-alpha is down-regulated by toll-like receptor agonists in microglial cells.Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson's disease.C/EBPβ and C/EBPδ transcription factors: Basic biology and roles in the CNS.Inhibition of CD200R1 expression by C/EBP β in reactive microglial cells.Inhibition of CCAAT/enhancer binding protein δ expression by chrysin in microglial cells results in anti-inflammatory and neuroprotective effects.Regulation of c-Ret, GFRalpha1, and GFRalpha2 in the substantia nigra pars compacta in a rat model of Parkinson's disease.PU.1 expression in microglia.Monoamine oxidases: from brain maps to physiology and transgenics to pathophysiology.Calcium deposit formation and glial reaction in rat brain after ibotenic acid-induced basal forebrain lesion.Long-term effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and 6-nitro-7-sulphamoylbenzo(f)quinoxaline-2,3-dione in the rat basal ganglia: calcification, changes in glutamate receptors and glial reactions.Differential vulnerability of hippocampus, basal ganglia, and prefrontal cortex to long-term NMDA excitotoxicity.Astrocytes are very sensitive to develop innate immune responses to lipid-carried short interfering RNA.Up-regulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington's disease revealed by quantitative enzyme radioautography.Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat.Intranigral infusion of interleukin-1beta activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity.High-yield isolation of murine microglia by mild trypsinization.Molecular neuroanatomy of monoamine oxidases in human brainstem.RGD domains neuroprotect the immature brain by a glial-dependent mechanism.Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia.Tungstate decreases weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation.Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia.CCAAT/enhancer binding protein β regulates prostaglandin E synthase expression and prostaglandin E2 production in activated microglial cells.Differential age-related changes of MAO-A and MAO-B in mouse brain and peripheral organs.CCAAT/enhancer binding protein δ regulates glial proinflammatory gene expression.Distribution of Clostridium perfringens epsilon toxin in the brains of acutely intoxicated mice and its effect upon glial cells.Age-related changes on MAO in Bl/C57 mouse tissues: a quantitative radioautographic study.Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro.CCAAT-enhancer binding protein alpha is expressed in activated microglial cells after brain injury.Upregulation of CCAAT/enhancer binding protein beta in activated astrocytes and microglia.
P50
Q28182081-C3BCDA94-7697-4E88-A02B-7EF7E8E7E902Q28196373-127F7A48-1F1E-4FD6-AB15-FE74E817EBA6Q28304258-BFA140A0-9BD8-4BD9-9E82-1CD080A42BDDQ28305137-B0A015A8-C765-442C-BD23-F4B2073EA146Q30480840-FD84124E-0F9B-4F41-8F0E-1B346AAF7BBDQ33634159-3EA52EB4-A908-4346-9352-3CEC9404043FQ34072253-65A0ABC6-FB9C-4F1A-8C4B-FAC84C9D8179Q34428405-898E8667-EF2A-4014-9F21-BA60B033436AQ34540602-2D26B6D0-4E12-49BA-84EC-17B404E7C17AQ36886226-DE317DC4-DACD-476C-A6CE-B04D52BE0235Q37708277-959E9A22-48FF-4752-BB72-5F1985909A93Q38305427-F96C427B-0D59-440D-904E-71A613750CCAQ38421118-D8AEBEC3-BEC7-48C0-85C3-09B9872BE657Q38542837-267DA380-F7F4-4D4D-BA0F-B0171C2F6151Q39317669-2963B016-D649-406A-BE99-A38FE98634CEQ39665702-E974B32F-4413-4C2F-975E-8AEBD1E42068Q40706788-606DF342-8FB9-4186-8793-4F77DAE113C6Q40894354-4D83627E-2C14-487F-BE46-D6B4EE167F36Q41752765-CDA28D42-CDF1-4C91-B799-BC9C8DE7549BQ42478210-BE74869F-A0FC-49A3-8919-757B12E936B6Q42481574-C5D5EEFA-A9B1-46E7-8F14-BB19839958FDQ42483998-90FB0BA2-5BC4-4D16-9A3C-1318FA0FC1F0Q42809435-1FBECBFE-EDB5-430F-824F-820ED12F58BFQ42817778-DC308872-15DC-4347-A679-6355C7D85B95Q44240001-0348C2E0-E482-46E9-A939-AA50948C391EQ44402824-7BE9428C-9016-44AA-B41C-9786266FCCA1Q44645887-C98B4756-1100-49C4-B413-1346449D9A80Q45080293-8438D93E-1EBC-4C84-9710-C8CB8E2F169AQ45870463-B7818678-D778-4D54-8C98-0BD4C7BE6EAAQ46643979-4E8FF9FD-B0EE-418D-AEFD-A5452A6AF3A5Q47375837-CFB3C40D-7A5E-4760-823B-2120FEBA127AQ47901926-0B258403-774F-431D-A41C-0B398A90F464Q47915476-45C66892-41FD-4234-AB77-1AC9DBF61814Q48096730-AC214A7F-3B88-44E9-878D-347059C1D639Q48113674-BE55FD1B-30B8-4564-862B-B8BC8BB329F3Q48134712-8406C907-7D23-41B2-88C8-5BCBEABE2819Q48223141-14A0DC7A-8FB1-4059-9B68-8FB59572E7A5Q48254313-41CAB2F1-5772-4C66-BD8E-A91988562B9AQ48364089-B24E88FD-42F9-4C78-B77C-AEBE6202AD42Q48381541-13FF85E8-060F-46A1-9800-F59213BF83F4
P50
description
Neurobiòleg
@ca
Neurobiólogo
@es
Spaans onderzoeker
@nl
neurobiologist
@en
name
Josep Saura
@ast
Josep Saura
@ca
Josep Saura
@en
Josep Saura
@es
Josep Saura
@ga
Josep Saura
@nl
Josep Saura
@sl
type
label
Josep Saura
@ast
Josep Saura
@ca
Josep Saura
@en
Josep Saura
@es
Josep Saura
@ga
Josep Saura
@nl
Josep Saura
@sl
altLabel
Josep Saura Martí
@ca
prefLabel
Josep Saura
@ast
Josep Saura
@ca
Josep Saura
@en
Josep Saura
@es
Josep Saura
@ga
Josep Saura
@nl
Josep Saura
@sl
P214
P1273
P1580
P21
P214
P27
P31
P496
0000-0002-5601-4466
P734
P735
P7859
viaf-305877736